(Q39102913)

English

PD1 and PDL1 expression in primary central nervous system diffuse large B-cell lymphoma are frequent and expression of PD1 predicts poor survival.

scientific article published on 13 December 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27966264%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

PD1 and PDL1 expression in primary central nervous system diffuse large B-cell lymphoma are frequent and expression of PD1 predicts poor survival (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27966264%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

B-cell lymphoma

1 reference

based on heuristic

inferred from title

diffuse large B-cell lymphoma

1 reference

based on heuristic

inferred from title

Vanessa Szablewski

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27966264%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

author name string

Marion Four

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27966264%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Valère Cacheux

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27966264%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Ariane Tempier

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27966264%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Dolorès Platero

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27966264%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Michel Fabbro

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27966264%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Grégory Marin

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27966264%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Nicolas Leventoux

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27966264%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Valérie Rigau

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27966264%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Valérie Costes-Martineau

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27966264%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

publication date

13 December 2016

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27966264%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Hematological Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27966264%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

35

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27966264%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27966264%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

487-496

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27966264%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Primary lymphoma of the central nervous system: epidemiology, pathology and current approaches to diagnosis, prognosis and treatment

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

p53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival time

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

Clinical significance of MYC expression and/or "high-grade" morphology in non-Burkitt, diffuse aggressive B-cell lymphomas: a SWOG S9704 correlative study

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

Prognostic clinicopathologic factors, including immunologic expression in diffuse large B-cell lymphomas.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

Prognostic significance of CD95, P53, and BCL2 expression in extranodal non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

Prognostic significance of aberrant promoter hypermethylation of CpG islands in patients with diffuse large B-cell lymphomas.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

Predictive Markers for the Efficacy of Anti-PD-1/PD-L1 Antibodies in Lung Cancer

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

PD-1 expression in T-cell lymphomas and reactive lymphoid entities: potential overlap in staining patterns between lymphoma and viral lymphadenitis

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

MYC protein expression in primary diffuse large B-cell lymphoma of the central nervous system

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

Expression of p53, c-Myc, or Bcl-6 suggests a poor prognosis in primary central nervous system diffuse large B-cell lymphoma among immunocompetent individuals

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

LIM domain only 2 protein expression, LMO2 germline genetic variation, and overall survival in diffuse large B-cell lymphoma in the pre-rituximab era.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

MYC/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

Interphase cytogenetic analysis of lymphoma-associated chromosomal breakpoints in primary diffuse large B-cell lymphomas of the central nervous system.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

Del(6)(q22) and BCL6 rearrangements in primary CNS lymphoma are indicators of an aggressive clinical course

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

PDL1 expression in inflammatory breast cancer is frequent and predicts for the pathological response to chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

Evaluation of the diagnostic and prognostic value of PDL1 expression in Hodgkin and B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

PD1 (CD279) and PD-L1 (CD274, B7H1) expression in primary central nervous system lymphomas (PCNSL).

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

Potential biomarker for checkpoint blockade immunotherapy and treatment strategy.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

Targetable genetic features of primary testicular and primary central nervous system lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

21 January 2018

Frequent triple-hit expression of MYC, BCL2, and BCL6 in primary lymphoma of the central nervous system and absence of a favorable MYC(low)BCL2 (low) subgroup may underlie the inferior prognosis as compared to systemic diffuse large B cell lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of oncogenic molecules in primary central nervous system lymphomas in immunocompetent patients

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival

1 reference

https://api.crossref.org/works/10.1002%2FHON.2375

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HON.2375

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27966264%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27966264%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39102913&oldid=1527272755"